HCK and acute myeloid leukemia: In the MV4-11 AML cell line, HCK was shown to be the SFK responsible for CDK6 overexpression downstream of FLT3-ITD, since only HCK targeting recapitulated the phenotypes (CDK6 expression and cell cycle arrest).